All
Maggot debridement therapy promising
March 1st 2004Akron, Ohio - Maggot debridement therapy (MDT), a controversial, but reportedly effective wound-healing technique, has attracted a following abroad in recent years, and is now gaining interest in the United States, as well. MDT is the medical use of live maggots or fly larvae for cleaning non-healing wounds. "MDT has been around for centuries -- so it's certainly not new, but there has been a resurgence of interest," said dermatologist and wound-care specialist Elliot N. Mostow, M.D., of Wound Care Associates of Akron (Ohio).
New topicals attack AK from myriad angles
March 1st 2004Waikoloa, Hawaii - Topical treatments for actinic keratosis can attack the problem internally and externally because of varying mechanisms of action, said James Del Rosso, D.O., as he reviewed advances in AK therapies Hawaii Dermatology Seminar.
Clinical variants dictate KS treatment
March 1st 2004Washington, D.C. - There are several clinical variants of Kaposi's sarcoma (KS), and appropriate treatment and response to treatment differ according to the clinical variant, according to Katie Pang, M.D., a clinical research fellow working with Dr. Stephen Tyring at the Center for Clinical Studies in Houston, Texas. The four major clinical variants are classic KS, KS in iatrogenically immunosuppressed patients, AIDS-related epidemic KS, and African endemic KS. HHV-8 is the etiological agent of all of the clinical types of KS.
New anti-dandruff foam looks promising
March 1st 2004Washington - A novel thermophobic foam containing three active ingredients to fight dandruff is at least as effective as standard anti-dandruff treatment, and offers the advantages of a non-greasy formulation that is fast-acting and not irritating to the hair or scalp, according to Massimo Milani, M.D., the medical director and head of technology and development at Mipharm SpA in Milan, Italy.
Less is more in rosacea patients' routine
March 1st 2004Waikoloa, Hawaii- When counseling rosacea patients on routine skincare products, the dermatologist's main mission is to keep the skincare simple and thus avoid the irritation that triggers an exacerbation of rosacea, according to Zoe D. Draelos, M.D.
To boutique, or not to boutique: that is the question
March 1st 2004Boutique. Concierge. Express service. There are a variety of names but the end result is the same: patients pay an annual retainer, and for that money - usually between $1000 to $2000 - patients receive a variety of special services: a smaller patient base which allows for no-wait appointments, longer appointments, and quicker return phone calls. It probably can not be called a trend yet, but a number of physicians around the country have dropped Medicare and others have stopped accepting managed care. Now, this new twist is being added - personalized medical care - for a fee.
Langerhans sarcoma: rare neoplasm
March 1st 2004Washington - Langerhans cell sarcoma is a rare neoplasm that can involve multiple organs, including lymph nodes, bone, lung, bone marrow, skin, and brain. A single, cutaneous tumor is an unusual primary presentation, said Tammie Ferringer, M.D., dermatopathology fellow at the Medical University of South Carolina.
Cryosurgery: cost-effective cancer cure
March 1st 2004Washington - Cryosurgery should be offered as a treatment option for a variety of skin cancers because it is an effective modality with numerous advantages, said Gloria F. Graham, M.D., at the annual meeting of the American Academy of Dermatology.
Etanercept shows safety, efficacy through five years
March 1st 2004Washington -- A new study presented in poster form at the recent AAD meeting concludes that etanercept continues to post an excellent record for the treatment of rheumatoid arthritis. The drug maintains its safety profile and clinical efficacy for treatment durations of more than five years.
Resolving hard-to-treat disorders
March 1st 2004Washington D.C. - In treating patients with non-responsive conditions, it's important to consider altering your method of inquiry, said Alan M. Dattner, M.D., FAAD. "I go beyond a clinical diagnosis to make an etiological diagnosis and treat on the basis of that," he said.
Digital cameras now ready for prime time
March 1st 2004La Jolla, Calif. - Digital cameras have improved so much in recent years that dermatologists should think seriously about purchasing and using one in their clinical practices. Instead of rifling through old slides in crowded file drawers or three ring binders, a doctor with a digital camera can store images on a computer and easily compare skin changes over time.
Organizing the topical antiaging product shelf
February 9th 2004Dermatologists and their patients have numerous cosmeceutical productsfrom which to choose. Doctors who categorize the agents can better helptheir patients understand how the novel therapies fit into skincare regimens.According to Zoe Diana Draelos, M.D., clinical associate professor ofdermatology, Wake Forest University School of Medicine, Winston Salem, N.C.,key cosmeceutical categories include: barrier-enhancing vitamins, receptor-mediatedvitamins, regulators of collagen breakdown, anti-inflammatories, exfoliates,and botanicals.
Dermatologists should be on front lines if bio-terrorism occurs
February 9th 2004Should a biological attack reach American soil, dermatologists must positionthemselves on the front lines, according to Michael J. Franzblau, M.D.,clinical professor of dermatology at the University of California at SanFrancisco's School of Medicine, and a respected researcher and speaker onbio-terrorism.
Hematoma is among the few emergencies in cutaneous surgery
February 8th 2004Taking a thorough patient history and performing precise surgery aretwo ways to avoid acute complications in cutaneous surgery, according toHugh M. Gloster, Jr., M.D., director of dermatologic surgery and Mohs micrographicsurgery, University of Cincinnati, Ohio. "However, if prevention fails,any physician who performs cutaneous surgery should be prepared to treathematoma, infection, dehiscence, and necrosis," he said.
Syndrome X - identification and treatment
February 7th 2004Washington D.C. - Stephen E. Chiarello, M.D., began his presentationat the AAD annual meeting yesterday by asking those attending the sessionhow many had heard of Syndrome X. Based on the number of hands raised, hesaid that more dermatologists seem to be aware of this condition, also calledMetabolic Syndrome, which affects 90 million Americans and finds its rootsin high glycerin and insulin levels.
Only medium, deep peels make dent in skin tightening
February 7th 2004Medium and deep peels are the only peels to give appreciable resultswith skin tightening. And properly performed phenol peels can eliminatewrinkles "extraordinarily better than any TCA peel," said HaroldJ. Brody, M.D., clinical professor of dermatology, Emory University, Atlanta,Ga. He is discussing the topic today at the AAD annual meeting.
Hematoma is among the few emergencies in cutaneous surgery
February 7th 2004Taking a thorough patient history and performing precise surgery aretwo ways to avoid acute complications in cutaneous surgery, according toHugh M. Gloster, Jr., M.D., director of dermatologic surgery and Mohs micrographicsurgery, University of Cincinnati, Ohio. "However, if prevention fails,any physician who performs cutaneous surgery should be prepared to treathematoma, infection, dehiscence, and necrosis," he said.
AADA urges FDA crackdown of internet-based isotretinoin sales
February 6th 2004Schaumburg, Ill. - The American Academy of Dermatology Association (AADA)urged the FDA to stop internet sales of isotretinoin, the active ingredientin Accutane, arguing that such sales pose potential health risks to thepublic. The statement was released at the AAD 2004 annual meeting.
Age of biologics on center stage as AAD 2004 kicks off
February 6th 2004Biologics in psoriasis are a hot buzzword asthe 62nd meeting of the American Academy of Dermatology hits stride today,with sources hailing the progression as a needed "new era." Technicalexhibits open today at 11 a.m. at the Wasington Convention Center, whilethe conference, symposia, and educational programs are in full gear.Dermatologists must enhance patients' understanding of biologics andmake them realize they have an option when other treatment modalities fail,sources added, as leveraging the patient-physician relationship is key.